Results 151 to 160 of about 22,798,456 (294)

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova, Jan Smeitink, Herma Renkema, Rosabeth White, Frankie Barton, Rachel Lyon, Jane Newman, Aye Moe, Yi Shiau Ng, Grainne Siobhan Gorman   +9 more
wiley   +1 more source

AI-Enabled Interpretation Guidance for Hemostasis Testing with TEG^® 6s. [PDF]

Diagnostics (Basel)
Hartmann J, Souter D, Dias JD, Sha Q.
europepmc   +1 more source

The standard for program management

, 2017
The Standard for Program Management – Fourth Edition differs from prior editions by focusing on the principles of good program management. Program activities have been realigned to program lifecycle phases rather than topics, and the first section was ...
Project Management Institute, Project Institute   +1 more
core  

Blood RNA Biomarker Signatures for Early Diagnosis and Prognosis in Ischemic and Hemorrhagic Stroke: The IBIS‐CT1 Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau, Marie Bruguet, Irina Viakhireva‐Dovganyuk, François‐Mathias Merrien, Denis Marechal, Aurore Jourdain, Philippe Goas, Jordan Coris, Julien Asselineau, Maëlys Consigny, Gérald Le Gac, Serge Timsit   +11 more
wiley   +1 more source

AI readiness for molecular precision medicine supply chains: evidence from Saudi Arabia. [PDF]

Front Digit Health
El-Nakib I, Soliman K.
europepmc   +1 more source

Progressive Parkinsonism in PPP2R5D‐Related Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT PPP2R5D‐related neurodevelopmental disorder (Houge–Janssens syndrome type 1) is a rare autosomal dominant condition characterized by macrocephaly, intellectual disability, and epilepsy. Progressive parkinsonism is an emerging adult phenotype that neurologists should be aware of since timely genetic diagnosis opens the door to disease‐modifying
Katerina Bernardi, Enrique Gonzalez Saez‐Diez, Joshua Rong, Beril Ay, Shabbir Merchant, Kathryn Yang, Darius Ebrahimi‐Fakhari   +6 more
wiley   +1 more source

A target product profile and roadmap for Japanese encephalitis diagnostics in endemic areas in the context of other flaviviruses. [PDF]

PLoS Negl Trop Dis
Bharucha T, Stokes L, Anane-Amponsah D, Abraham AM, Auewarakul P, Awal B, Belludi AY, Bondre V, Damodar T, de Lamballerie X, Dhodapkar R, Dubot-Pérès A, Duong V, Easton A, Evans R, Grabovac V, Gupta N, Huong NHT, Khan SA, Kinhal UV, Krishnasamy K, Lim CK, Lodha L, Malavige GN, Mammen S, Mayxay M, Miraclin T A, Mukhopadhyay L, Mulders M, Munivenkatappa A, Noronha AK, Ooi MH, Otter A, Pasco P, Pattassery SA, Radera S, Gowda VK, Reddy V, Rupali P, Saravu K, Sangal L, Saysanasongkham S, Shakoor S, Srinavasan K, Sultana S, M A A, Singh B, Solomon T, S Y AK, Van Tan L, Tetteh KKA, Trung TH, Turtle L, Vasanthapuram R, Venkataswamy MM, Vu NT, Wilkinson RJ, Zangmo S, Mani R, Dittrich S.   +59 more
europepmc   +1 more source

Diagnostic Imaging Information Improving the Quality of Clinical Management

Practica Oto-Rhino-Laryngologica, 2006
openaire   +2 more sources

The Price of Precision: A Critical Review of Molecular Diagnostics in Glioma, From Guidelines to Global Disparities

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Gliomas have undergone a profound redefinition over the past decade, transitioning from morphology‐based entities to biologically coherent diseases defined by molecular alterations. The 2021 WHO Classification of Tumors of the Central Nervous System and its 2022 update formalize this shift, establishing integrated diagnosis as the global ...
Maria Guarnaccia, Sebastiano Cavallaro
wiley   +1 more source

Clinician-Reported Respiratory Viral Testing and Intended Management of Community-Acquired Respiratory Viral Infections in Haematology and Haematopoietic Cell Transplantation: An International Exploratory Survey. [PDF]

Diagnostics (Basel)
du Toit JR, Neijzen TR, van der Bie S, van Lelyveld SFL, Beeker A, van Stralen KJ, Vlek OM, Verburgh ER, van Gorp E, Versluis J, Goeijenbier M.   +10 more
europepmc   +1 more source